Τόμος 15 (2001) – Τεύχος 1 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 15 (2001) – Issue 1 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1.       Alexandra General Hospital, Athens, Greece

2.      Technological Educational Institution of Athens, Egaleo, Athens, Greece

3.      Department of Nursing, University of Athens, Athens, Greece

Accepted for publication: 25 November 2000

pharmakonpress[at]pharmakonpress[.]gr

2.    American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (4^th ed.), American Psychiatric Association, Washington DC, 1994

3.    Βαρώνος Δ.: Ιατρική Φαρμακολογία (Τόμ.. Β’, 5^η έκδοση).σελ. 64, 329- 333, 371- 376, Γ. Παρισιάνος, Αθήνα, 1987

4.    Κίτσιου-Τζέλη Σ.: Τερατογόνοι Παράγοντες και Συγγενείς Ανωμαλίες, σελ. 135-160, Αθήνα, 1992

5.    Chasnoff I.J.: Newborn infants with drug withdrawal symptoms. Pediatr. Rev. 9C9: 273 (1988)

6.    Besuder J.B., Blumer J.L.: Neonatal drug withdrawal syndromes, in: Maternal-Fetal Toxicology (Koren G., Ed.) pp. 161-190, Marcel Dekker Inc, 1990

7.    Boobis S., Sullivan F.M.: Effects of life-style on reproduction. In: Drugs and Chemical Action in Pregnancy (Fabro S., Scialli A.Ft., eds) pp. 373-425, Marcel Dekker Inc, 1986

8.    Briggs G.G., Freeman R.K., Yaffe S.J.: Drugs in Pregnancy and Lactation. In: A Reference Guide to Fetal and Neonatal Risk (4^th ed.), (Mitchell C.W., ed), pp. 112- 118, Williams & Wilkins, Baltimore, 1994

9.    Bunker M.L., Me Williams M.: Caffeine content of common beverages. J. Am. Diet. Assoc. 74: 28-32 (1979)

10.  Harvey R., Champe P., et al: Pharmacology: Lippincott’ s Illustrated Reviews, pp. 91-95, 101-104, J. B. Lippincott Company, 1992

11.  Linn S., Schoenbaum S.C., Monson R.R., et al: No association between coffee consumption and adverse outcomes in pregnancy. N. Engl. J. Med. 306: 141 (1982)

12.  Fortier I.: Relation of caffeine intake during pregnancy to intrauterine retardation and preterm birth. Am. J. Epidemiol. 137: 931-940 (1993)

13.  Katzung B., Trevor A.: Pharmacology. Examination & Board Review (5^th ed.), pp. 246,179-180, Appleton & Lange, Connecticut, 1998

14.  Rosett H.: A clinical perspective of the fetal alcohol syndrome. Alcohol. Clin. Exp. Res. 4: 119-122 (1980)

15.  Rosett H.L., Weiner L., Edelin K.C.: Strategies for prevention of fetal alcohol effects. Obstet. Gynecol. 57: 1 (1981)

16.  Church M.W., Abel E.L.: Fetal Alcohol syndrome: Hearing, Speech, Language, and Vestibular Disorders. Obstet. Gynecol. Clin. North Am. 25: 85-94 (1998)

17.  Chernoff G.F.: The fetal alcohol syndrome in mice. Maternal variables. Teratology 22: 71 (1980)

18.  Mulvihill J.J.: Fetal alcohol syndrome. In: Teratogen Update: Environmentally Induced Birth Defects (Sever S.L., Brent R.L, eds), pp. 13-18, Alan R Liss, 1986

19.  Council on Scientific Affairs, American Medical Association: Fetal effects of maternal use. JAMA 242: 2517-2521 (1983)

20.  Abel E.L; Fetal Alcohol Abuse Syndrome Revised. Plenum Press, New York, 1997

21.  Jones K.L., Smith D.W.: Recognition of the fetal alcohol syndrome in early infancy. Lancet 2: 999-1001 (1973)

22.  Kefala V., Kostara l., Karageorgiou H., Varonos D.: In Vitro Model for Evaluation of Medicines Phototoxic Activity. Rev. Clin. Pharmacol. Pharmacok. 14: 43-47 (2000)

23.  Coles C.D.; Early neurobehavioral assessment of children prenatally exposed to alcohol. In: Fetal Alcohol Syndrome: From Mechanism to Prevention {Abel L, ed), pp. 148, CRC Press, Boca Raton, 1996

24.  Chiriboga C.A.: Cocaine and the fetus: Methodological issue and neurological correlates. In: Prenatal Cocaine Exposure (Konkol R.J., Olsen G.D., eds), CRC Press, Boca Raton, 1996

25.  Becker M., Warr-Leeper G.A., Leeper H.A.: Fetal alcohol syndrome: A description of oral motor, articulatory, short-term memory, grammatical, and semantic abilities. J. Commun. Disord. 23: 97-124 (1990)

26.  Conry J.: Neuropsychological deficits in fetal alcohol syndrome and fetal alcohol effects. Alcohol. Clin. Exp. Res. 14: 650-655 (1990)

27.  Streissguth A.P.: Neonatal effects of alcohol use. In: Clinical Manual of Substance Abuse (14^th ed.) CV Mosby, St. Louis, 1991

28.  Wagner C., Katikaneni L., Cox T., Ryan R.: The impact of prenatal drug exposure on the neonate. Obstet. Gynecol. Clin. North Am. 25: 169-194 (1998)

29.  Church M.W., Holloway J.A.: The effects of prenatal alcohol exposure on postnatal development of the brainstem auditory evoked potential in the rat. Alcohol. Clin. Exp. Res. 8: 258-263 (1984)

30.  Paparella M.M., Schachern P.A.: Sensorineural hearing loss in children-nongenetic. In: Otolaryngology (Paparella M.M., Shumrick D.A., Gluckman J.L., Meyer W.L., eds), (vol 2, 3^rd ed.), pp. 1561-1578, W.B. Saunders, 1991

31.  Church M.W., Eldis F.: Correlation between craniofacial, hearing, and language disorders in the Fetal Alcohol Syndrome. Alcohol. Clin. Exp. Res. 55: 57 (1997)

32.  Church M.W., Eldis F., Blakley B.W., et al.: Hearing, speech, language, vestibular and dentofacial disorders in the Fetal Alcohol Syndrome (FAS). Alcohol. Clin. Exp. Res. 21: 227-237 (1997)

33.  Church M.W., Gerkin K.P.: Hearing disorders in children with Fetal Alcohol Syndrome: Findings from case reports. Pediatrics 82: 147-154 (1988)

34.  Olegard R., Sabel K.G., Aronsson M., et al.: Effects on the child of alcohol abuse during pregnancy. Acta Paediatr. Scand. 275 (supp): 112-121 (1979)

35.  Day N.L., Jasperse D., Ritsardson G., et al: Prenatal exposure to alcohol: Effect on infant growth and morphologic characteristics. Pediatrics 84: 536-541 (1989)

36.  Maier S.E., Wei-Jung A.C., West J.R.: The effects of timing and duration of alcohol exposure on development of the fetal brain. In: Fetal Alcohol Syndrome: From Mechanism to Prevention (Abel L.E., ed), pp. 27-50, CRC Press, Boca Raton, 1996

37.  Armant D.R.: Ethanol-induced acceleration of preimplantation embryonic development. In: Fetal Alcohol Syndrome: From Mechanism to Prevention (Abel L., ed), pp. 1-26, CRC Press, Boca Raton, 1996

38.  Habbick B.: Fetal alcohol syndrome in Saskatchewan: unchanged incidence in a 20-year period. Can. J. Public Health 87: 204-207 (1996)

39.  Κοκκέβη A., Στεφάνής K.: Τα Ναρκωτικά στην Ελλάδα: Η διαχρονική πορεία της χρήσης. Ερευνητικό Πανεπιστημιακό Ινστιτούτο Ψυχικής Υγείας, σελ. 71-78, 191-197, Αθήνα,1994

40.  Lewis D., Woods S.: Fetal alcohol syndrome. Am. Fam.Phys. 50: 1025-1032 (1994)

41.  Johnston L.D., O’Malley P.M., Bachman J.G.: National survey results on drug use. In: MD, Department of Health and Human Services, National Institutes of Health, The Monitoring The Future Study, 1975-1993, vol. I, Secondary School Students, Rockville, 1994

42.  Jones H.E., Balster R.L.: Inhalant abuse in pregnancy. Obstet. Gynecol. Clin. North Am. 25: 153-164 (1998)

43.  Evans E.B., Balster R.L.: CNS depressant effects of volatile organic solvents. Neurosci. Biobehav. Rev. 15: 233 (1991)

44.  Meirik O., Kullen B., Gauffin U., et al.: Major malformations in infants born to women who worked in laboratories while pregnant. Lancet 1: 91 (1979)

45.  Holmberg P.C., Nurminen M.: Congenital defects of the central nervous system and occupational factors during pregnancy. Am. J. Ind. Med. 1: 167 (1980)

46.  McDonald J.C., Lavoie J., CntG R., et al.: Chemical exposures at work in early pregnancy and congenital defect: A case referent study. Br. J. Ind. Med. 44: 527 (1987)

47.  Holmberg P.C., Hernberg S., Kurppa K„ et al.: Oral clefts and organic solvent exposure during pregnancy. Int. Arch. Occup. Environ. Health 50: 371 (1982)

48.  Cordier S., Ha Μ-C., Ayme S., et al.: Maternal occupational exposure and congenital malformations. Scand. J. Work Environ. Health 18: 11 (1992)

49.  Tikkanen J., Heinonen O.P.: Risk factors for ventricular septal defect in Finland. Public Health 105: 99 (1991)

50.  Eskenazi B., Bracken M.B., Holford T.R., et al.: Exposure to organic solvents and hypertensive disorders in pregnancy. Am. J. Ind. Med. 14: 177 (1988)

51.  Lindbohm M.L.: Effects of parental exposure to solvents on pregnancy outcome. J. Occup. Environ. Med. 37: 908 (1995)

52.  Toutant C., Lippmann S.: Fetal solvents syndrome. Lancet 1: 1356 (1979)

53.  Hersh J.H.: Toluene embryopathy: Two new cases. J. Med. Genet. 28: 333 (1989)

54.  Wilkins-Haug L., Gabow P.A.: Toluene abuse during pregnancy: Obstetric complications and perinatal outcomes. Obstet. Gynecol. 7: 504 (1991)

55.  Arnold G.L., Kirby R.S., Langendoerfer S., et al.: Toluene-embryopathy: Clinical delineation and developmental follow-up. Pediatrics 98: 216 (1994)

56.  Pearson M.A., Hoyme H.E., Seaver L.H., et al.: Toluene embryopathy: Delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics 98: 211 (1994)

57.  Abel E.L.: Smoking and pregnancy. J. Psychiatr. Drugs 18: 327-338 (1984)

58.  Floyd R., Zahniser S., Gunter E., et al.: Smoking during pregnancy: Prevalence, effects, and intervention strategies. Birth 18: 48-53 (1991)

59.  Andres R.L, Jones K.L.: Social and illicit drug use in pregnancy. In: Maternal-Fetal Medicine: Principles and Practice (Creasy R.K., Resnik R., Eds), pp. 182-198, W.B. Saunders, Philadelphia, 1994

60.  Simpson W.J.: A preliminary report on cigarette smoking and the incidence of prematurity. Am. J. Obstet. Gynecol. 73: 808-815 (1957)

61.  Koren G.: Fetal toxicology of environmental tobacco smoke. Curr. Opin. Pediatr. 7: 128-135 (1995)

62.  Armitage A., Dollery C., George C., et al.: Absorption and metabolism of nicotine from cigarettes. BMJ 4: 313- 315 (1975)

63.  Resnik R., Brink G., Wilkes M.: Catecholamine- mediated reduction in uterine blood flow after nicotine infusion in the pregnant ewe. J. Clin. Invest. 63: 1113-1136 (1979)

64.  Lambers D.S., Clark K.E.: The maternal and fetal physiologic effects of nicotine. Semin. Perinatol. 20: 115 (1096)

65.  National Institute of Drug and Alcohol Abuse: National pregnancy and health survey-drug use among women delivering live births. MD, NCADI Publication no. BKD 192, 1992

66.  Ventura S.J., Martin J.A., Taffel S.M., et al.: Advanced report of final natality statistics, 1993. Month Vital Stat. Report 44: 1-88 (1995)

67.  Prager K., Malin H., Spregler D., et al.: Smoking and drinking behavior before and during pregnancy of married mothers of live-born infants and stillborn infants. Public Health Rep. 99: 118-127 (1984)

68.  Abel E.L.: Prenatal exposure to cannabis: A critical review of effects on growth, development, and behavior. Behav. Neural Biol. 25: 137-156 (1980)

69.  Dollan-Mullen P., Ramirez G., Groff J.: A metaanalysis of randomized trials of prenatal smoking cessation interventions. Am. J. Obstet. Gynecol. 171: 1328-1334 (1994)

70.  Luck W., Nau H.,,\ Hansen R., et al.: Extent of nicotine and continue transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev. Pharmacol. Ther. 8: 384-395 (1985)

71.  Ferguson B., Wilson D., Schaffner W.: Determination of nicotine concentrations in human milk. Am. J. Dis. Child. 130: 837-839 (1976)

72.  Manning F., Feyerabend C.: Cigarette smoking and fetal breathing movements. Br. J. Obstet. Gynaecol. 83: 262-270 (1976)

73.  Lindblad A., Marsal K., Andersson K.: Effects of nicotine on human fetal blood flow. Obstet. Gynecol. 72: 371-382 (1988)

74.  Starko G.: Correlation of meconium-stained amniotic fluid, early intrapartum PH and Apgar scores as predictors of prenatal outcome. Obstet. Gynecol. 56: 604-609 (1980)

75.  Economides D., Braithwaite J.: Smoking, pregnancy and the fetus. J. R. Soc. Health 114: 198-201 (1994)

76.  Walsh R.: Effects of maternal smoking on adverse pregnancy outcomes: Examination of the criteria of causation. Hum. Biol. 66: 1059-1092 (1994)

77.  Perrson P., Grennert L., Gennser G., et al.: A study of smoking and pregnancy with special reference to fetal growth. Acta Obstet. Gynecol. Scand. 78: 33-39 (1978)

78.  Andrews J., McGarry J.: A community study of smoking in pregnancy. J. Obstetrics and Gynecology of the British Commonwealth 78: 1057-1073 (1972)

79.  Naeye R.: Abruptio placentae and placenta previa: Frequency, perinatal mortality and cigarette smoking. Obstet. Gynecol. 55: 701-704 (1980)

80.  Eskenazi B., Bergman J., Trupin L.: Passive and active maternal smoking during pregnancy, as measured by serum cotinine, and postnatal smoke exposure. I. Effects of physical growth at age 5 years [and] II. Effects on neurodevelopment at age 5 years. Am. J. Epidemiol. 142(9): S10-S29 (1980)

81.  Christianson R.: Gross differences observed in the placentas of smokers and non-smokers. Am. J. Epidemiol. 110: 178-187 (1979)

82.  Jauniaux E., Graham J.B.: The effect of smoking in pregnancy on early placental morphology. Obstet. Gynecol. 79: 645-648(1992)

83.  Himmelberger D.U., Brown B.W., Cohen W.N.: Cigarette smoking during pregnancy and the occurrence of spontaneous abortion and congenital abnormality. Am. J. Epidemiol. 708: 470-479 (1978)

84.  Kelsey I., Dayer I., Holford T., Bracker M.: Maternal smoking and congenital malformations: An epidemiologic study. J. Epidemiol. Commun, Health 32: 102 (1978)

85.  Christensen R.: The relationship between maternal smoking and the incidence of congenital anomalies. Am. J. Epidemiol. 112: 684 (1980)

86.  BOUD J., Bout.’] A., Lazar P.: Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions. Teratology 12: 11-26 (1975)

87.  Ellard G.A., Johnstone F.D., Prescott R.J., et al.: Smoking during pregnancy: The dose dependence of birth weight deficits. Br. J. Obstet. Gynaecol. 103: 806-813 (1996)

88.  Peacock J.L., Bland J.M., Anderson H.R., et al.: Cigarette smoking and birthweigth: Type of cigarette smoked and a possible threshold effect. Int. J. Epidemiol. 20: 405-412 (1991)

89.  Leiberman E., Gremy I., Lang J.M., et al.: Low birthweigth at term and the timing of fetal exposure to maternal smoking. Am. J. Public Health 84: 1127-1131 (1994)

90.  Kyerematen G., Vesell E.: Metabolism of nicotine. Drug Metab. Rev. 23: 3-41. (1991)

91.  Oncken C.A., Hatsukamî D.K., Lupo V.R., et al.: Effects of short-term use of nicotine gum in pregnancy smokers. Clin. Pharmacol. Ther. 59: 654-661 (1996)

92.  Tager I.B., Long N., Hanrahan J.P.: Maternal smoking during pregnancy: Effects on lung function during the first 18 months of life. Am. J. Resp. Crit. Care Med. 152: 977- 983 (1995)

93.  Taylor B.: Prevention of pediatric pulmonary problems: The importance of maternal smoking. Lung 168(supp.): 327-332 (1990)

94.  Magnusson C.G.: Maternal smoking influences cord serum IgE and IgD levels and increases the risk for subsequent infant allergy. J. Allergy Clin. Immun 78: 898- 904(1986)

95.  Beratis N.G., Panagoulias D., Varvarigou A.: Increased blood pressure in neonates and infants whose mothers smoked during pregnancy. Pediatrics 128: 806-812 (1996)

96.  Klonoff-Cohen H.S., Edelstein S.L., Lefkowitz E.S., et al.: The effect of passive smoking and tobacco exposure through breast milk on sudden infant death syndrome. JAMA 273: 795-798 (1996)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr